Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Pelletier

Showing results (101-110 of 134) with videos related to

Pageof 14
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|October 24, 2022
Neurofilament Light Chain Levels Are Predictive of Clinical Conversion in Radiologically Isolated SyndromeManon Rival, Eric Thouvenot, Lucile Du Trieu de Terdonck, et al.
The Lancet. Neurology|March 24, 2012
Association between pathological and MRI findings in multiple sclerosisMassimo Filippi, Maria A Rocca, Frederik Barkhof, et al.
Multiple Sclerosis and Related Disorders|January 21, 2021
Alemtuzumab outcomes by age: Post hoc analysis from the randomized CARE-MS studies over 8 yearsAnn D Bass, Rafael Arroyo, Aaron L Boster, et al.
BMC Neurology|November 15, 2013
Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot studyTanuja Chitnis, Charles R Guttmann, Alexander Zaitsev, et al.
CNS Drugs|July 26, 2020
Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension StudyTjalf Ziemssen, Ann D Bass, Regina Berkovich, et al.
Genes and Immunity|March 20, 2026
Increased VH4+JH6+ antibody heavy chain use in plasmablasts from asymptomatic multiple sclerosis patientsSara Benavides, Scott Christley, Kiel M Telesford, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 30, 2022
Toward Precision Phenotyping of Multiple SclerosisDavid Pitt, Chih Hung Lo, Susan A Gauthier, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 30, 2017
Radiologically isolated syndrome in children: Clinical and radiologic outcomesNaila Makhani, Christine Lebrun, Aksel Siva, et al.
Neurology|April 25, 2018
Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyAlexander Rae-Grant, Gregory S Day, Ruth Ann Marrie, et al.
Neurology|April 25, 2018
Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyAlexander Rae-Grant, Gregory S Day, Ruth Ann Marrie, et al.
Pageof 14

Showing results (101-110 of 134) with videos related to

Sort By:
Pageof 14
Neurology(R) Neuroimmunology & Neuroinflammation|October 24, 2022
Neurofilament Light Chain Levels Are Predictive of Clinical Conversion in Radiologically Isolated SyndromeManon Rival, Eric Thouvenot, Lucile Du Trieu de Terdonck, et al.
The Lancet. Neurology|March 24, 2012
Association between pathological and MRI findings in multiple sclerosisMassimo Filippi, Maria A Rocca, Frederik Barkhof, et al.
Multiple Sclerosis and Related Disorders|January 21, 2021
Alemtuzumab outcomes by age: Post hoc analysis from the randomized CARE-MS studies over 8 yearsAnn D Bass, Rafael Arroyo, Aaron L Boster, et al.
BMC Neurology|November 15, 2013
Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot studyTanuja Chitnis, Charles R Guttmann, Alexander Zaitsev, et al.
CNS Drugs|July 26, 2020
Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension StudyTjalf Ziemssen, Ann D Bass, Regina Berkovich, et al.
Genes and Immunity|March 20, 2026
Increased VH4+JH6+ antibody heavy chain use in plasmablasts from asymptomatic multiple sclerosis patientsSara Benavides, Scott Christley, Kiel M Telesford, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 30, 2022
Toward Precision Phenotyping of Multiple SclerosisDavid Pitt, Chih Hung Lo, Susan A Gauthier, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 30, 2017
Radiologically isolated syndrome in children: Clinical and radiologic outcomesNaila Makhani, Christine Lebrun, Aksel Siva, et al.
Neurology|April 25, 2018
Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyAlexander Rae-Grant, Gregory S Day, Ruth Ann Marrie, et al.
Neurology|April 25, 2018
Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyAlexander Rae-Grant, Gregory S Day, Ruth Ann Marrie, et al.
Pageof 14